HCPCS Level II · Drugs administered other than oral method
J0175Injection, donanemab-azbt, 2 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J0175
J0175 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, donanemab-azbt, 2 mg.
It was added to HCPCS effective 07/02/2024.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj, donanemab-azbt, 2 mg
- Date added
- 07/02/2024
- Action effective
- 07/02/2024
- BETOS
- O1E
Related J01xx codes
- J0120Injection, tetracycline, up to 250 mg
- J0121Injection, omadacycline, 1 mg
- J0122Injection, eravacycline, 1 mg
- J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0130Injection abciximab, 10 mg
- J0131Injection, acetaminophen, not otherwise specified,10 mg
- J0132Injection, acetylcysteine, 100 mg
- J0133Injection, acyclovir, 5 mg
- J0134Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg
- J0136Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
- J0137Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
- J0138Injection, acetaminophen 10 mg and ibuprofen 3 mg
Common questions about J0175
Is HCPCS J0175 still valid?
- Yes. J0175 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J0175?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.